118 related articles for article (PubMed ID: 26424162)
41. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and anti-hepatitis C virus activity of 2'(beta)-hydroxyethyl and 4'(alpha)-hydroxymethyl carbodine analogues.
Liu LJ; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2009 Nov; 28(11):1007-15. PubMed ID: 20183569
[TBL] [Abstract][Full Text] [Related]
43. β-D-2'-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms.
Zhou L; Zhang HW; Tao S; Bassit L; Whitaker T; McBrayer TR; Ehteshami M; Amiralaei S; Pradere U; Cho JH; Amblard F; Bobeck D; Detorio M; Coats SJ; Schinazi RF
J Med Chem; 2015 Apr; 58(8):3445-58. PubMed ID: 25849312
[TBL] [Abstract][Full Text] [Related]
44. Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials.
Elfiky AA
J Med Virol; 2016 Dec; 88(12):2044-2051. PubMed ID: 27604059
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetics of IDX184, a liver-targeted oral prodrug of 2'-methylguanosine-5'-monophosphate, in the monkey and formulation optimization for human exposure.
Pan-Zhou XR; Mayes BA; Rashidzadeh H; Gasparac R; Smith S; Bhadresa S; Gupta K; Cohen ML; Bu C; Good SS; Moussa A; Rush R
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):567-74. PubMed ID: 25898809
[TBL] [Abstract][Full Text] [Related]
46. Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.
Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Yueh A; Wang JC; Hsu TA; Chao YS; Chern JH
Bioorg Med Chem Lett; 2009 Nov; 19(21):6063-8. PubMed ID: 19796940
[TBL] [Abstract][Full Text] [Related]
47. Antiviral resistance and the future landscape of hepatitis C virus infection therapy.
Wyles DL
J Infect Dis; 2013 Mar; 207 Suppl 1():S33-9. PubMed ID: 23390303
[TBL] [Abstract][Full Text] [Related]
48. Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.
Draffan AG; Frey B; Fraser BH; Pool B; Gannon C; Tyndall EM; Cianci J; Harding M; Lilly M; Hufton R; Halim R; Jahangiri S; Bond S; Jeynes TP; Nguyen VT; Wirth V; Luttick A; Tilmanis D; Pryor M; Porter K; Morton CJ; Lin B; Duan J; Bethell RC; Kukolj G; Simoneau B; Tucker SP
Bioorg Med Chem Lett; 2014 Nov; 24(21):4984-8. PubMed ID: 25288185
[TBL] [Abstract][Full Text] [Related]
49. Molecular design, synthesis, and biological evaluation of bisamide derivatives as cyclophilin A inhibitors for HCV treatment.
Han J; Lee HW; Jin Y; Khadka DB; Yang S; Li X; Kim M; Cho WJ
Eur J Med Chem; 2020 Feb; 188():112031. PubMed ID: 31923861
[TBL] [Abstract][Full Text] [Related]
50. Discovery of naphtho[1,2-d]oxazole derivatives as potential anti-HCV agents through inducing heme oxygenase-1 expression.
Tseng CH; Lin CK; Chen YL; Tseng CK; Lee JY; Lee JC
Eur J Med Chem; 2018 Jan; 143():970-982. PubMed ID: 29232587
[TBL] [Abstract][Full Text] [Related]
51. Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus.
Feng JY; Xu Y; Barauskas O; Perry JK; Ahmadyar S; Stepan G; Yu H; Babusis D; Park Y; McCutcheon K; Perron M; Schultz BE; Sakowicz R; Ray AS
Antimicrob Agents Chemother; 2016 Feb; 60(2):806-17. PubMed ID: 26596942
[TBL] [Abstract][Full Text] [Related]
52. INX-08189, a phosphoramidate prodrug of 6-O-methyl-2'-C-methyl guanosine, is a potent inhibitor of hepatitis C virus replication with excellent pharmacokinetic and pharmacodynamic properties.
Vernachio JH; Bleiman B; Bryant KD; Chamberlain S; Hunley D; Hutchins J; Ames B; Gorovits E; Ganguly B; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters CR; Wang J; Williams K; Patti JM; Henson G; Madela K; Aljarah M; Gilles A; McGuigan C
Antimicrob Agents Chemother; 2011 May; 55(5):1843-51. PubMed ID: 21357300
[TBL] [Abstract][Full Text] [Related]
53. Discovery of ASP5286: A novel non-immunosuppressive cyclophilin inhibitor for the treatment of HCV.
Makino T; Yoshimura S; Neya M; Yamanaka T; Sawada M; Tsujii E; Barrett D
Bioorg Med Chem Lett; 2020 Aug; 30(16):127308. PubMed ID: 32631528
[TBL] [Abstract][Full Text] [Related]
54. Synthesis of 3',4'-difluoro-3'-deoxyribonucleosides and its evaluation of the biological activities: discovery of a novel type of anti-HCV agent 3',4'-difluorocordycepin.
Shimada H; Haraguchi K; Hotta K; Miyaike T; Kitagawa Y; Tanaka H; Kaneda R; Abe H; Shuto S; Mori K; Ueda Y; Kato N; Snoeck R; Andrei G; Balzarini J
Bioorg Med Chem; 2014 Nov; 22(21):6174-82. PubMed ID: 25282652
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of purine modified 2'-C-methyl nucleosides as potential anti-HCV agents.
Zhang HW; Zhou L; Coats SJ; McBrayer TR; Tharnish PM; Bondada L; Detorio M; Amichai SA; Johns MD; Whitaker T; Schinazi RF
Bioorg Med Chem Lett; 2011 Nov; 21(22):6788-92. PubMed ID: 21983447
[TBL] [Abstract][Full Text] [Related]
56. Structure-activity relationship studies on quinoxalin-2(1H)-one derivatives containing thiazol-2-amine against hepatitis C virus leading to the discovery of BH6870.
Zhong QF; Liu R; Liu G
Mol Divers; 2015 Nov; 19(4):829-53. PubMed ID: 26205408
[TBL] [Abstract][Full Text] [Related]
57. The discovery and characterization of a novel scaffold as a potent hepatitis C virus inhibitor.
Liu N; Zhu S; Zhang X; Yin X; Dong G; Yao J; Miao Z; Zhang W; Zhang X; Sheng C
Chem Commun (Camb); 2016 Feb; 52(16):3340-3. PubMed ID: 26822629
[TBL] [Abstract][Full Text] [Related]
58. Discovery of a novel 9-position modified second-generation anti-HCV candidate via bioconversion and semi-synthesis of FR901459.
Makino T; Ishida J; Yamanaka T; Ohki H; Uchida M; Sawada M; Barrett D
Bioorg Med Chem Lett; 2020 Sep; 30(18):127423. PubMed ID: 32731088
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and evaluation of novel potent HCV NS5A inhibitors.
Zhang H; Zhou L; Amblard F; Shi J; Bobeck DR; Tao S; McBrayer TR; Tharnish PM; Whitaker T; Coats SJ; Schinazi RF
Bioorg Med Chem Lett; 2012 Jul; 22(14):4864-8. PubMed ID: 22704887
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in vitro.
Sellitto G; Faruolo A; de Caprariis P; Altamura S; Paonessa G; Ciliberto G
Bioorg Med Chem; 2010 Aug; 18(16):6143-8. PubMed ID: 20638289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
